SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

TriSalus Life Sciences, Inc.
Date: Dec. 2, 2025 · CIK: 0001826667 · Accession: 0001826667-25-000137

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-291509

Date
December 2, 2025
Author
Mary Szela
Form
CORRESP
Company
TriSalus Life Sciences, Inc.

Letter

Document TRISALUS LIFE SCIENCES, INC. 6272 W. 91 st . Ave. Westminster, Colorado 80031 December 2, 2025 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Nick O’Leary Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 File No. 333-291509 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, TriSalus Life Sciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Time, on Thursday, December 4, 2025, or as soon thereafter as possible. Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Registrant, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. TRISALUS LIFE SCIENCES, INC. By: /s/ Mary Szela Name: Mary Szela Title: Chief Executive Officer

Show Raw Text
CORRESP
 1
 filename1.htm

 Document TRISALUS LIFE SCIENCES, INC. 6272 W. 91 st . Ave. Westminster, Colorado 80031 December 2, 2025 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Nick O’Leary Re: TriSalus Life Sciences, Inc. Registration Statement on Form S-3 File No. 333-291509 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, TriSalus Life Sciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 9:00 a.m., Eastern Time, on Thursday, December 4, 2025, or as soon thereafter as possible. Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Registrant, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. TRISALUS LIFE SCIENCES, INC. By: /s/ Mary Szela Name: Mary Szela Title: Chief Executive Officer